Revenue
No reported data
ProMIS Neurosciences Inc. (PMN)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Research & development | $33.4M | $10.6M | $7.9M | $16.1M | $4.6M |
| Operating expenses | $40.2M | $16.8M | $14.3M | $23.4M | $8.3M |
| Operating income | −$40.2M | −$16.8M | −$14.3M | −$23.4M | −$8.3M |
| EBITDAderived | — | — | −$14.2M | −$23.4M | −$8.2M |
| Net income | −$39.7M | $2.8M | −$13.2M | −$18.1M | −$9.8M |
| Basic EPSper diluted share | -$22.61 | $2.68 | -$1.07 | -$2.41 | -$1.69 |
| Diluted EPSper diluted share | -$22.61 | $2.63 | -$1.07 | -$2.41 | -$1.69 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 22, 2026Form 4 | Kirwin Patrick D.Director | BuyCommon Shares · indirect | 4.0K | $11.33 | $45.3K | 4.7K |
| Mar 5, 2026Form 4 | Williams EugeneDirector | BuyCommon Shares | 2.0K | $24.40 | $48.8K | 12.4K |
| Mar 4, 2026Form 4 | Williams EugeneDirector | BuyCommon Shares | 2.0K | $24.00 | $48.0K | 10.4K |
| Mar 3, 2026Form 4 | Williams EugeneDirector | BuyCommon Shares | 1.0K | $21.89 | $21.9K | 8.4K |
| Mar 2, 2026Form 4 | Williams EugeneDirector | BuyCommon Shares | 1.0K | $22.53 | $22.5K | 7.4K |